Trials / Recruiting
RecruitingNCT07106021
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
A Phase 1b/2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Kenai Therapeutics · Industry
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RNDP-001 | Stem cells |
| DEVICE | Syringe Front-Loading Device | Delivers the stem cells |
Timeline
- Start date
- 2025-07-17
- Primary completion
- 2027-09-01
- Completion
- 2031-06-01
- First posted
- 2025-08-06
- Last updated
- 2026-01-23
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07106021. Inclusion in this directory is not an endorsement.